Krishnan Nandabalan
Fundador en BioXcel Corp. .
Perfil
Krishnan Nandabalan is the founder of BioXcel Corp.
which was founded in 2005, where he holds the titles of President, Secretary & Director.
Currently, he is the Chairman, President & Chief Executive Officer at Invea Therapeutics, Inc. since 2021, President, Chief Executive Officer & Director at InveniAI LLC, and an Advisor at Autism Impact Fund.
Dr. Nandabalan's former positions include Director at Technology Systems from 1998 to 2000, Vice President-Corporate Development at Genaissance Pharmaceuticals, Inc. from 2004 to 2005, Director at AyuGen Biosciences Pvt Ltd.
from 2006 to 2015, and Director & Chief Digital Officer at BioXcel Therapeutics, Inc. from 2017 to 2023.
Dr. Nandabalan's education includes a doctorate from the Indian Institute of Science and undergraduate and graduate degrees from Tamilnadu Agricultural University.
Cargos activos de Krishnan Nandabalan
Empresas | Cargo | Inicio |
---|---|---|
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Fundador | 01/01/2005 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Director Ejecutivo | 01/11/2021 |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | Consultor / Asesor | - |
Inveniai LLC | Director Ejecutivo | - |
Antiguos cargos conocidos de Krishnan Nandabalan.
Empresas | Cargo | Fin |
---|---|---|
BIOXCEL THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/09/2023 |
AyuGen Biosciences Pvt Ltd.
AyuGen Biosciences Pvt Ltd. Medical/Nursing ServicesHealth Services AyuGen Biosciences Pvt Ltd. is a private organization founded in 2005 that focuses on specialized genomic tests and services. The private company is based in Pune, India. The Indian company's mission is to provide world-class preventive and diagnostic genomic tests to correctly identify the cause of the disease, and subsequently treat it with the correct medicine and right dose to minimize potential side effects. AyuGen aims to bridge the gaps between the current medical practices and the new "personalized" genomic based medical practices for prevention and better treatment. | Director/Miembro de la Junta | 01/10/2015 |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Director Técnico/Científico/I+D | 01/10/2000 |
Technology Systems
Technology Systems Computer Processing HardwareElectronic Technology Part of Aryt Industries Ltd., Technology Systems is an American company with five decades of ocean domain experience. The company's unique blend of editorial and marketing expertise helps their industry clients to expand their reach and deepen their message. Technology Systems was acquired by Aryt Industries Ltd. on September 12, 2000 for $5 million. | Director/Miembro de la Junta | 01/10/2000 |
Formación de Krishnan Nandabalan.
Indian Institute of Science | Doctorate Degree |
Tamilnadu Agricultural University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOXCEL THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
Technology Systems
Technology Systems Computer Processing HardwareElectronic Technology Part of Aryt Industries Ltd., Technology Systems is an American company with five decades of ocean domain experience. The company's unique blend of editorial and marketing expertise helps their industry clients to expand their reach and deepen their message. Technology Systems was acquired by Aryt Industries Ltd. on September 12, 2000 for $5 million. | Electronic Technology |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Technology Services |
AyuGen Biosciences Pvt Ltd.
AyuGen Biosciences Pvt Ltd. Medical/Nursing ServicesHealth Services AyuGen Biosciences Pvt Ltd. is a private organization founded in 2005 that focuses on specialized genomic tests and services. The private company is based in Pune, India. The Indian company's mission is to provide world-class preventive and diagnostic genomic tests to correctly identify the cause of the disease, and subsequently treat it with the correct medicine and right dose to minimize potential side effects. AyuGen aims to bridge the gaps between the current medical practices and the new "personalized" genomic based medical practices for prevention and better treatment. | Health Services |
Autism Impact Fund
Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | Finance |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
Inveniai LLC |
- Bolsa de valores
- Insiders
- Krishnan Nandabalan